Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flumazenil for Axial Motor Impairments in PD
NCT03462641Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Mar 2018
- Primary completion
- Jun 2021
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of flumazenil in Parkinson's disease (PD), sponsored by University of Michigan. Started Mar 2018; status: completed.
02
Drugs
flumazenil
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03462641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03462641.